|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 19, 2017 ) Market Overview
“Congenital Heart Disease -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Congenital Heart Disease. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Congenital Heart Disease by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.
The report information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Request Sample Copy of this report @ https://www.precisemarketreports.com/report/sample/pmr-62207
Key Players:
• Shanghai iCELL Biotechnology Co
• AstraZeneca
• Ethicare GmbH
• Bristol-Myers Squibb
• Vertex Pharmaceuticals Incorporated
• Gilead Sciences
• Stealth BioTherapeutics Inc.
• Actelion
• Bracco Diagnostics Inc
• Japan Regenerative Medicine Co. Ltd.
• Edwards Lifesciences
• Asklepion Pharmaceuticals
• LG life science
• Mallinckrodt
• Mylan Pharmaceuticals
& list continues...
Scope of the report
• The report provides a snapshot of the pipeline development for the Congenital Heart Disease
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Congenital Heart Disease
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Congenital Heart Disease
• The report also covers the dormant and discontinued pipeline projects related to the Congenital Heart Disease
Get 20% Discount on this report @ https://www.precisemarketreports.com/report/discount/pmr-62207
Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Congenital Heart Disease to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Congenital Heart Disease therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress
Purchase this report @ https://www.precisemarketreports.com/paypal/checkout/pmr-62207
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Precise Market Reports
Ashish M
+1 (323) 744 6588
sales@precisemarketreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
